Pharmeasy Reports A Record-Setting Positive EBITDA Of Rs 14 Crore: Implications…?
PharmEasy has instilled hope for fundraising and investment with its latest EBITDA reports. The company took significant steps, like delaying its IPO in 2022 and focusing on reducing the cash…